Radiopharmaceutical:Central Nervous System

[M1B1C4] Development of imaging agents specific to GLT excluding the off-target binding.

Hiroshi Yamaguchi^1,2,3,6, Takuya Sumi⁴, Jiyoung Kang^4,5, Maki Okada⁶, Keiichi Yamashiro³, Masaru Tateno⁴ (1.Nagoya University Brain & Mind Research Center, Aichi, Japan, 2.Nagoya University Graduate School of Medicine, Aichi, Japan, 3.Nagoya University Hospital, Aichi, Japan, 4.University of Hyogo Graduate School of Life Science, Hyogo, Japan, 5.Institute of Human Complexity and Systems Science, System Science Center for Brain and Cognition, Yonsei University College of Medicine, Seoul, South Korea, 6.National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan)